NobleAI Appoints Alex Wang as Chief Executive Officer to Lead Next Phase of Growth and Innovation Former VMware strategy leader to guide NobleAI's Science-Based AI platform through its next phase of growth in chemistry and energy innovation GlobeNewswire December 05, 2025 SAN FRANCISCO, Dec. 05, 2025 (GLOBE NEWSWIRE) — NobleAI, the leader in practical AI […]
Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 05, 2025 BEDFORD, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to eight newly hired non-executive employees. The awards were
Iridex to Present at the Sidoti Year-End Virtual Investor Conference GlobeNewswire December 05, 2025 MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to participate in
Koryx Copper Provides Update on Zambia Projects with Definition of Drill Targets at Luanshya West and Completion of Regional Surface Geochemistry at Mpongwe GlobeNewswire December 05, 2025 Highlights: Multiple targets identified and confirmed for drill testing at Luanshya West. Successful drone magnetic survey, in-fill and extension of soil sampling, and pitting programs completed at Luanshya
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio's CORDStrom(TM) Platform GlobeNewswire December 05, 2025 Boca Raton, FL, Dec. 05, 2025 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a clinical-stage inflammation and immunology company, announces a recently published overview of future applications and
Mirasol Announces Change in Chief Financial Officer GlobeNewswire December 05, 2025 VANCOUVER, British Columbia, Dec. 05, 2025 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTC: MRZLF) (the “Company” or “Mirasol“) announces that Carmen Cazares has retired from her role as Chief Financial Officer (“CFO”) of the Company. The Company is also pleased to announce
Gaming and Leisure Properties Provides Updates on Recent Financing and Development Activities GlobeNewswire December 05, 2025 WYOMISSING, Pa., Dec. 05, 2025 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (the “Company” or “GLPI”) today provided updates on several recent progress milestones associated with four operating partners across five projects. In total, these five
Victoria's Secret & Co. Reports Third Quarter 2025 Results and Raises Full Year Guidance GlobeNewswire December 05, 2025 Delivered Net Sales of $1.472 Billion, a 9% Increase Versus Prior Year, Exceeding Expectations Operating Results and Earnings Exceed Expectations Raises Fiscal Year 2025 Net Sales, Operating Income and Earnings Guidance REYNOLDSBURG, Ohio, Dec. 05, 2025 (GLOBE
OTC Markets Group Welcomes Silver47 Exploration Corp. to OTCQX GlobeNewswire December 05, 2025 NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Silver47 Exploration Corp. (TSX-V: AGA; OTCQX: AAGAF), a mineral exploration company, has qualified to trade
Wugen to Present Correlative Data and Long-Term Follow-Up Updates for Off-the-Shelf, Allogeneic CD7-Targeted CAR-T Cell therapy at the 2025 ASH Annual Meeting — Results from the Phase 1/2 Trial are a Foundation for the Ongoing Pivotal Study of Soficabtagene Geleucel for R/R T-Cell ALL/ LBL in Pediatric and Adult Patients GlobeNewswire December 05, 2025 ST.